Finally, as a result of their putative kinase function, PINK1 and LRRK2 are attractive potential targets in the treatment of PD and cancer even though their potential influence in tumour growth remains mostly indirect and suggestive thus far (see Table 1; [1], [96], [97]). Here, PINK1 is linked to Parkinson disease.